The effectiveness and success of an immunization protocols not only rely on the immunogenicity and quality of the antigenic preparation. The incorporation of adjutants and immunostimulants in vaccines to enhance protection against disease in human beings and commercial animals has been a center issue for the pharmaceutical industry since it beginning. Also, the antibody producing industry requires powerful immunostimulants and carriers for the production of antibodies in high yields against small drugs, hormones, peptides for research and diagnostic. Therefore, the development and the search for new adjutants and immunostimulants is decisive to succeed.